<DOC>
	<DOCNO>NCT01359722</DOCNO>
	<brief_summary>The purpose study determine possible effect nephroprotective N-acetylcysteine patient chronic kidney disease undergo elective coronary artery bypass graft serial evaluation renal function evaluate whether treatment reduces cardiac mortality , cardiac event Global mortality , interfere oxidative stress inflammation need dialysis .</brief_summary>
	<brief_title>N-acetylcysteine Prevent Renal Failure</brief_title>
	<detailed_description>Renal failure serious relatively frequent complication cardiac surgery observe , especially diabetic pre-existing renal dysfunction . Given oxidative stress elevate diabetic renal heart , reasonable speculate involvement pathophysiology complication . It unknown whether incidence postoperative renal failure reduce antioxidant . N-acetylcysteine ( NAC ) antioxidant prevents nephropathy induce contrast medium aminoglycosides increase intracellular level cyclic guanosine monophosphate , act vasodilator platelet inhibitor . Based knowledge pathophysiology ARF , several intervention attempt past decade . However , various measure employ successfully prevention experimental ARF result success clinical practice . Much failure probably due difference experimental model ARF encounter clinic . Other factor consider , may explain poor result clinical trial : time use drug , dosage route administration , always adequate . From data literature , remain doubtful whether protective role NAC limit contrast nephropathy whether could application clinical situation oxidative stress vasoconstriction determinant injury , occur , example , CABG surgery . NAC drug low cost low toxicity , paper intend assess role prophylaxis renal dysfunction postoperative period CABG patient chronic kidney disease stag 3 4 ( GFR 15 59 mL/min/1 , 73 m2 body surface ) .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>adult patient age 30 80 year old sexes indicate elective CABG glomerular filtration rate , assess MDRD &lt; 60 mL/min/1 , 73 m2 &gt; 15 mL / min / 1.73 m2 body surface patient chronic dialysis creatinine &gt; 5 mg / dL preoperatively ; individual allergic intolerant Nacetylcysteine pregnant woman patient cancer patient underwent resurgery within first 72 hour postoperatively</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>N-acetylcysteine</keyword>
	<keyword>Myocardial Revascularization</keyword>
	<keyword>Acute Renal Failure</keyword>
	<keyword>Oxidative Stress</keyword>
</DOC>